완전정맥마취에 의한 수술 중 Hydroxyethyl Starch (130/0.4) 용액의 동시투여가 혈소판 기능에 미치는 영향 = The effect of intraoperative colloid solutions coadministered with 6% hydroxyethyl starch (130/0.4) on platelet function in patients undergoing total intravenous anesthesia

다국어 초록 (Multilingual Abstract)

Background: Colloid solutions are used to treat hypovolemia and expanding plasma, but they may inhibit platelet function and reduce the level of coagulation factors during surgery. This study was conducted to compare the effects of hydroxyethyl starch (HES) on adenosine diphosphate (ADP)- and collagen-induced platelet aggregation in patients undergoing total intravenous anesthesia.
Methods: Patients undergoing endoscopic sinus surgery under total intravenous anesthesia with propofol and remifentanil were divided into a group that underwent fluid management with only crystalloid solution (n = 15) and a group that was managed with crystalloid solution that included 6% HES (130/0.4) (n = 15). ADP- and collagen-induced platelet aggregation were measured 5 minutes before induction, after the first intraoperative hour, and one hour postoperatively.
Results: Significantly diminished ADP- and collagen-induced aggregation values were observed intraoperatively when compared with the preoperative value in the patients that were managed with colloid solution that included HES. In addition, significantly diminished collagen-induced aggregation values were observed intraoperatively when compared with the preoperative value in the group that was managed with the solution that only contained the crystalloid. However, ADP- and collagen-induced platelet aggregation were recovered postoperatively in both groups.
Conclusions: The results of this study indicated that fluid therapy with colloid solution that contained 6% HES (130/0.4) may diminish ADP-induced platelet aggregation intraoperatively in patients subjected to total intravenous anesthesia.

다국어 초록 (Multilingual Abstract)

Background: Colloid solutions are used to treat hypovolemia and expanding plasma, but they may inhibit platelet function and reduce the level of coagulation factors during surgery. This study was conducted to compare the effects of hydroxyethyl starch (HES) on adenosine diphosphate (ADP)- and collagen-induced platelet aggregation in patients undergoing total intravenous anesthesia.
Methods: Patients undergoing endoscopic sinus surgery under total intravenous anesthesia with propofol and remifentanil were divided into a group that underwent fluid management with only crystalloid solution (n = 15) and a group that was managed with crystalloid solution that included 6% HES (130/0.4) (n = 15). ADP- and collagen-induced platelet aggregation were measured 5 minutes before induction, after the first intraoperative hour, and one hour postoperatively.
Results: Significantly diminished ADP- and collagen-induced aggregation values were observed intraoperatively when compared with the preoperative value in the patients that were managed with colloid solution that included HES. In addition, significantly diminished collagen-induced aggregation values were observed intraoperatively when compared with the preoperative value in the group that was managed with the solution that only contained the crystalloid. However, ADP- and collagen-induced platelet aggregation were recovered postoperatively in both groups.
Conclusions: The results of this study indicated that fluid therapy with colloid solution that contained 6% HES (130/0.4) may diminish ADP-induced platelet aggregation intraoperatively in patients subjected to total intravenous anesthesia.

참고문헌 (Reference)

1 Langeron O, "Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5" 92 : 855-862, 2001

2 Dogan IV, "The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation" 88 : 432-436, 1999

3 Hirakata H, "The effect of inhaled anesthetics on platelet aggregation and the ligand-binding affinity of the platelet thromboxane A2 receptor" 81 : 114-118, 1995

4 Blaicher AM, "The effect of hydroxyethyl starch on platelet aggregation in vitro" 86 : 1318-1321, 1998

5 Stogermuller B, "The effect of hydroxyethyl starch 200 kD on platelet function" 91 : 823-827, 2000

6 Kirakata H, "Sevoflurane inhibits human platelet aggregation and thromboxane a2 formation, possibly by suppression of cyclooxygenase activity" 85 : 1447-1453, 1996

7 Neilsen VG, "Resuscitation with Hextend decreases endogenous circulating heparin activity and accelerates clot initiation after hemorrhage in the rabbit" 93 : 1106-1110, 2001

8 손수창, "Propofol과 Remifentanil을 사용한 완전정맥마취가 혈소판 기능에 미치는 영향" 대한마취과학회 54 (54): 134-138, 2008

9 Turkan H, "Propofol does not affect platelet aggregation" 13 : 408-409, 1996

10 Hirakata K, "Platelet aggregation is impaired during anesthesia with sevoflurane but not with isoflurane" 44 : 1157-1161, 1997

11 Yardumian DA, "Laboratory investigation of platelet function. a review of methodology" 39 : 701-712, 1986

12 Mayne A, "Intravenous infusion of propofol for induction and maintenance of anaesthesia during endoscopic carbon dioxide laser ENT procedures with high frequency jet ventilation" 43 : 97-100, 1988

13 Boldt J, "Intravascular volume replacement therapy with synthetic colloids: Is there an influence in renal function?" 96 : 376-382, 2003

14 Scharbert G, "Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia" 99 : 823-827, 2004

15 Treib J, "Influence of intravascular molecular weight of hydroxyethyl starch on platelets" 56 : 168-172, 1996

16 Ruttmann TG, "In vivo investigation into the effect of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation" 80 : 612-616, 1998

17 Ng KFJ, "In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial" 88 : 475-480, 2002

18 Huraux C, "Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group" 92 : 1396-1401, 2001

19 Ruttmann TG, "Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery" 89 : 226-230, 2002

20 Walter F, "Effects of halothane on cyclic 3',5'-adenosine monophosphate enzyme system in human platelets" 59 : 856-861, 1980

21 Santoso JT, "Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy" 82 : 252-256, 2001

22 de Jonge E, "Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects" 27 : 1825-1829, 2001

23 Treib J, "Coagulation disorders caused by hydroyethyl starch" 78 : 974-983, 1997

24 Deusch E, "Blinding of hydroxyethyl starch molecules to the platelet surface" 97 : 680-683, 2003

25 De La Cruz JP, "Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes" 128 : 1538-1544, 1999

26 Treib J, "An international view of hydroxyethyl starches" 25 : 258-268, 1999